XML 21 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Common Stock Warrants (Details Textual) (USD $)
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2007
Jun. 30, 2012
Jun. 30, 2012
Jun. 04, 2012
Dec. 31, 2011
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]          
Common stock, shares issued   45,143,363 45,143,363   43,416,200
Common stock, shares outstanding   45,143,363 45,143,363   43,416,200
Warrants Granted     200,000    
Common stock warrants (Textual) [Abstract]          
Exercise price per share     1.43    
Albitar Warrant Period     5 years    
Value Of Warrants   $ 130,678 $ 130,678    
Stock compensation expense   $ 15,000 $ 32,500    
Warrants exercised       100,000  
No Of Shares Inexchange Of Cashless Net Exercise Of Warrants     10,571    
Warrants Issued 348,417        
Warrant [Member]
         
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]          
Common stock, shares issued   550,000 550,000    
Plasma Prostate Cancer Test Licensed From Health Discovery Corp HDC [Member]
         
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]          
Warrants Granted     80,000    
Colon Cancer Test Licensed From HDC [Member]
         
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]          
Warrants Granted     40,000    
Pancreatic Cancer Test Licensed From HDC [Member]
         
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]          
Warrants Granted     40,000    
Cytogenetics Automated Image Analysis Technology Licenses From HDC [Member]
         
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]          
Warrants Granted     20,000    
Cytometry Automated Image Analysis Technology Licenses From HDC [Member]
         
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]          
Warrants Granted     20,000